Production and characterization of polyclonal and monoclonal antibodies to the zeta (zeta) opioid receptor.
about
Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancerRegulation of Tenon's capsule fibroblast cell proliferation by the opioid growth factor and the opioid growth factor receptor axis.Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis.New therapeutic approaches in the treatment of diabetic keratopathy: a review.Opioid system and Alzheimer's disease.Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer.Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer.Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model.Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin.Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.The opioid growth factor, [Met5]-enkephalin, inhibits DNA synthesis during recornification of mouse tail skin.Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing.Targeted overexpression of OGFr in epithelium of transgenic mice suppresses cell proliferation and impairs full-thickness wound closure.Presence of opioid growth factor and its receptor in the normal dog, cat and horse cornea.
P2860
Q33511045-AD263423-69ED-4C9B-AE18-C5F2265E26D7Q33686632-BEA574C8-95EC-49C7-8FA0-551BE67DE934Q34735305-A0BDD958-9F71-483E-A0CF-E8DB46EF1D2DQ34965037-C0D608CB-2413-4B15-832A-7D61AB5AE164Q37802919-A4EDAD7C-F56A-4447-A3B8-B8B1DCC01D45Q38004941-11F2D3C2-7EBF-4D1F-B0E9-F4CB5B08C00DQ39114818-B494BB8D-5DD3-4A61-8A2E-DC6F9BE38F50Q39397468-B198C8DB-3178-4687-876D-997E4C700B85Q39496812-33617A36-5572-4A5A-8538-639A2E7FE46BQ39522079-77AD5832-2238-4943-8A8C-3D7281AB6C6BQ39813287-F1C21AA3-08E6-48D7-8CCC-F19149C5217DQ42488962-8F800A12-7FF8-4BFB-B3DE-878344A6CBB2Q42799555-0F9B6BB6-ABD2-429D-8405-936258CB8EDAQ44031670-8B16E6F5-EC4E-4578-A268-45473C54B12DQ44341590-77723C59-02F9-4B1F-98C8-03EF8E1D30D2
P2860
Production and characterization of polyclonal and monoclonal antibodies to the zeta (zeta) opioid receptor.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Production and characterizatio ...... e zeta (zeta) opioid receptor.
@en
Production and characterization of polyclonal and monoclonal antibodies to the zeta
@nl
type
label
Production and characterizatio ...... e zeta (zeta) opioid receptor.
@en
Production and characterization of polyclonal and monoclonal antibodies to the zeta
@nl
prefLabel
Production and characterizatio ...... e zeta (zeta) opioid receptor.
@en
Production and characterization of polyclonal and monoclonal antibodies to the zeta
@nl
P1433
P1476
Production and characterizatio ...... e zeta (zeta) opioid receptor.
@en
P2093
P J McLaughlin
P304
P356
10.1016/0006-8993(93)90669-E
P407
P577
1993-12-01T00:00:00Z